Tourette syndrome
Tourette syndrome or Tourette's syndrome (abbreviated as TS or Tourette's) is a common neurodevelopmental disorder that begins in childhood or adolescence. It is characterized by multiple movement (motor) tics and at least one vocal (phonic) tic. Common tics are blinking, coughing, throat clearing, sniffing, and facial movements. These are typically preceded by an unwanted urge or sensation in the affected muscles, can sometimes be suppressed temporarily, and characteristically change in location, strength, and frequency. Tourette's is at the more severe end of a spectrum of tic disorders. The tics often go unnoticed by casual observers.

Tourette's was once regarded as a rare and bizarre syndrome and has popularly been associated with coprolalia (the utterance of obscene words or socially inappropriate and derogatory remarks). It is no longer considered rare; about 1% of school-age children and adolescents are estimated to have Tourette's, and coprolalia occurs only in a minority. There are no specific tests for diagnosing Tourette's; it is not always correctly identified, because most cases are mild, and the severity of tics decreases for most children as they pass through adolescence. Therefore, many go undiagnosed or may never seek medical attention. Extreme Tourette's in adulthood, though sensationalized in the media, is rare, but for a small minority, severely debilitating tics can persist into adulthood. Tourette's does not affect intelligence or life expectancy.

There is no cure for Tourette's and no single most effective medication. In most cases, medication for tics is not necessary, and behavioral therapies are the first-line treatment. Education is an important part of any treatment plan, and explanation alone often provides sufficient reassurance that no other treatment is necessary. Among those who are referred to specialty clinics, other conditions like attention deficit hyperactivity disorder (ADHD) and obsessive–compulsive disorder (OCD) are more likely than in the broader population of persons with Tourette's. These co-occurring diagnoses often cause more impairment to the individual than the tics; hence it is important to correctly distinguish co-occurring conditions and treat them.

Tourette syndrome was named by French neurologist Jean-Martin Charcot for his intern, Georges Gilles de la Tourette, who published in 1885 an account of nine patients with a "convulsive tic disorder". While the exact cause is unknown, it is believed to involve a combination of genetic and environmental factors. The mechanism appears to involve dysfunction in neural circuits between the basal ganglia and related structures in the brain.
Q3450985
neurodevelopmental disorder
Concept
Q738538
tic
Concept
Q7575316
spectrum
Concept
Q1077139
tic disorder
Concept
Q179630
syndrome
Concept
Q125466
coprolalia
Concept
Q188419
life expectancy
Concept
Q16262180
behavioral therapies
MEDIA
Q31207
specialty clinics
Concept
Q181923
attention deficit hyperactivity disorder
Concept
Q178190
obsessive–compulsive disorder
Concept
Q1414874
co-occurring diagnoses
Concept
Q83042
neurologist
Concept
Q20710
Jean-Martin Charcot
PER
Q437732
Georges Gilles de la Tourette
PER
Q7162
genetic
Concept
Q4866181
dysfunction
Concept
None
neural circuits
UNK
Q464210
basal ganglia
Concept
Q191779
Tourette syndrome
Concept
Q191779
Tourette syndrome
Concept
1885-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1885
DATE
+1^^http://www.w3.org/2001/XMLSchema#decimal
1
NUMBER
symptoms and signs
subclass of
health specialty
named after
field of work
field of work
student